Search
Search site

View the Patent Register

With effect from 1 March 2012, the Intellectual Property Office took over responsibility for the registration and administration of patents from the Greffe and the Royal Court.

The table below details the patents that have been registered in the Bailiwick of Guernsey and their current status.

Register Search -

If you wish to search for a specific Patent or Proprietor please press 'Ctrl F' in order to search this web page.

More detailed information regarding the original application and any subsequent administration can be found by requesting a Statement of the Register. This can be obtained by emailing ipo@guernseyregistry.com, attaching a pdf icon Request for copy documents [471kb] form and details of payment (£25 - uncertified copy, £50 - certified copy).

Should you require any further information please call the office on +44 1481 743800 or email: ipo@guernseyregistry.com.

Last updated: 02/10/2017

Guernsey Reference Patent TitleProprietor NameOverseas JurisdictionOverseas ReferencePatent Status
GG-GP513Modulators of ATP-Binding Cassette transportersVertex Pharmaceuticals IncorporatedThe European Patent OfficeEP2365972Current
GG-GP512Key and disc tumbler cylinder lockAbloy OyThe European Patent OfficeEP2815045Current
GG-GP5112-methylmorpholine pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKuDOS Pharmaceuticals LimitedThe European Patent OfficeEP2057156Current
GG-GP510Lipidated immune response modifier compound compositions, formulations, and methods3M Innovative Properties CompanyEuropean (UK)EP2606047Current
GG-GP509Glucagon/GLP-1 receptor co-agonistsIndiana University Research & Technology CorporationUnited KingdomEP2723367Current
GG-GP508Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofPfizer Inc.The European Patent OfficeEP2445883Current
GG-GP507Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitorsPfizer Products Inc.European (UK)EP1869019Current
GG-GP5061,2,4-triazine-4-amine derivativesHeptares Therapeutics LimitedEuropean (UK)EP2531492Current
GG-GP5055-phenyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl carboxamides as JAK inhibitorsGalapagos N.VEuropean (UK)EP2445911Current
GG-GP504Pharmaceutical formulation 514AstraZeneca UK LimitedEuropean (UK)EP2346495Current
GG-GP503Oxygenated esters of 4-iodo phenylamino benzhydroxamic acidsWarner-Lambert Company LLCEuropean (UK)EP1301472Current
GG-GP502Antiviral compoundsGilead Pharmasset LLCEuropean (UK)EP2430014Current
GG-GP501Inhibitors of hepatitis C virusGilead Sciences, Inc.European (UK)EP2870160Current
GG-GP500Condensed imidazolylimidazoles as antiviralcompoundsGilead Pharmasset LLCEuropean (UK)EP2635588Current
GG-GP499Compounds and their use as BACE inhibitorsAstraZeneca ABEuropean (UK)EP2655378Current
GG-GP498Aminoheteroaryl compounds as protein kinaseinhibitorsSugen, Inc.European (UK)EP2476667Current
GG-GP497Heterocyclic modulators of ATP-binding cassette transportersVertex Pharmaceuticals IncorporatedEuropean (UK)EP2774925Current
GG-GP496Apoptosis signal-regulating kinase inhibitorGilead Sciences, Inc.European (UK)EP2807151Current
GG-GP495Automatic injectorMeridian Medical Technologies, Inc.European (UK)EP2311510Current
GG-GP494A method for fitting a braMARKS AND SPENCER PLCUnited KingdomEP2997841Current
GG-GP493Dihydropyrazolopyrimidinone derivativeMSD K.K.United KingdomEP2017278Current
GG-GP492Benzodioxinyl substituted indazole derivativesAstrazeneca AB & Bayer Pharma AktiengesellschaftUnited KingdomEP2291369Current
GG-GP491Modulators of atp-binding cassette transportersVERTEX PHARMACEUTICALS INCORPORATEDUnited KingdomEP2771345Current
GG-GP490Fused bicyclic oxazolidinone cetp inhibitorMERCK SHARP & DOHME CORP.United KingdomEP2771345Current
GG-GP489Bicycloaniline derivativeMSD K.K.United KingdomEP2168966Current
GG-GP488Heterobifunctional pan-selectin inhibitorsGlycoMimetics, Inc.United KingdomEP1934236Current
GG-GP487DRIVER PROFILING SYSTEM AND METHODMyDrive Solutions LimitedEuropean (UK)EP2619059Current
GG-GP486Disc tumbler cylinder lockAbloy OYUnited KingdomEP2902569Current
GG-GP485Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activityViiV Healthcare Company & Shionogi & Co., Ltd.United KingdomEP2465580Current
GG-GP484Modulators of toll-like receptorsGilead Sciences, Inc.United KingdomEP2364314Current
GG-GP483Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitorsWyeth Holdings LLCUnited KingdomEP2253620Current
GG-GP482Aminoheteroaryl compounds as protein kinase inhibitorsSugen, Inc.United KingdomEP1603570Current
GG-GP481Crystals including a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, processes for its preparation and compositions thereofPharmacia & Upjohn Company LLCUnited KingdomEP1419151Current
GG-GP480Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agentPfizer Products Inc.United KingdomEP1945186Current
GG-GP479Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the sameWyeth LLCUnited KingdomEP1902029Current
GG-GP478Nucleoside phosphoramidate prodrugsGilead Pharmasset LLCUnited KingdomEP2203462Current
GG-GP4773-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptorsIncyte CorporationUnited KingdomEP1696919Current
GG-GP476Magnetic tunnel junction (mtj) and method for forming the sameQualcomm IncorporatedUnited KingdomEP2419933Current
GG-GP475Magnetic random access memory (mram) layout with uniform patternQualcomm IncorporatedUnited KingdomEP2625689Current
GG-GP474On-chip low voltage capacitor-less low dropout regulator with q-controlQualcomm IncorporatedUnited KingdomEP2564284Current
GG-GP473Semi-persistent scheduling grants in heterogeneous networksQualcomm IncorporatedUnited KingdomEP2561713Current
GG-GP472Adaptive resource negotiation between base stations for enhanced interference coordinationQualcomm IncorporatedUnited KingdomEP2559291Current
GG-GP471Cqi estimation in a wireless communication networkQualcomm IncorporatedUnited KingdomEP2559182Current
GG-GP470Feedback of control information for multiple carriersQualcomm IncorporatedUnited KingdomEP2556618Current
GG-GP469System and method to read and write data at a magnetic tunnel junction elementQualcomm IncorporatedUnited KingdomEP2382633Current
GG-GP468Word line voltage control in stt-mramQualcomm IncorporatedUnited KingdomEP2353164Current
GG-GP467Low output skew double data rate serial encoderQualcomm IncorporatedUnited KingdomEP2055008Current
GG-GP466Code division multiplexing in a single-carrier frequency division multiple access systemQualcomm IncorporatedUnited KingdomEP1922830Current
GG-GP465Transmit spatial diversity for cellular single frequency networksQualcomm IncorporatedUnited KingdomEP1894317Current
GG-GP464Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity

Viv Healthcare Company &

Shionogi & Co, Ltd

United KingdomEP1874117Current
GG-GP4632-(2,4,5-substituted-anilino) pyrimidine derivatives as egfr modulators useful for treating cancerASTRAZENECA ABUnited KingdomEP2736895Current
GG-GP462Animal identification system and related methodChamberlain, Chamberlain & SmithUnited States of AmericaUS9,007,218 B2Current
GG-GP461Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their useMERCK SHARP & DOHME CORPUnited KingdomEP2485736Current
GG-GP460Inhibitors of hepatitis c virus replicationMERCK SHARP & DOHME CORP.United KingdomEP2410844Current
GG-GP459Certain triazolopyrazines, compositions thereof and methods of use thereforHutchison Medipharma LimitedUnited KingdomEP2719699Current
GG-GP458Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS, INC.United KingdomEP2581078Current
GG-GP457Tigecycline compositions and methods of preparationWYETH LLCUnited KingdomEP1858488Current
GG-GP456Echinocandin pharmaceutical formulations containing micelle-forming surfactantsELI LILLY & COMPANYUnited KIngdomEP1582204Current
GG-GP455Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES, INCUnited KingdomEP2822954Current
GG-GP4543-((3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitorPFIZER PRODUCTS INC.United KingdomEP1666481Current
GG-GP453Micronized CaCO3 slurry injection system for the remineralization of desalinated and fresh waterOmya International AGUnited KingdomEP2548848Current
GG-GP452Inhalation composition containing aclidinium for treatment of chronic obstructive pulmonary diseaseALMIRALL S.A.United KingdomEP2265257Current

GG-

GP451

Dibenzothiazepine derivative and use thereofASTRAZENECA ABThe European Patent OfficeEP2307389Current
GG-GP450Intrauterine depositMERCK SHARP & DOHME B.V.European (UK)EP2211794Current
GG-GP449Non-nucleoside reverse transcriptase inhibitorsMERCK CANADA INC.United Kingdom2552902Current

GG-

GP448

Combinations comprising antimuscarinic agents and beta-adrenergic agonistsALMIRALL S.A.United Kingdom2774623Current

GG-

GP447

Vaccine comprising an oil in water emulsion adjuvantGLAXOSMITHKLINE BIOLOGICALS S.A.

United

Kingdom

EP2086582Current

GG-

GP446

Chromenone derivatives with anti -tumour activityASTRAZENECA ABUnited Kingdom2493870Current
GG-GP445Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842ASTRAZENECA ABUnited KingdomEP2167502Current

GG-

GP444

Pyrazinone derivatives and their use in the treatment of lung diseasesASTRAZENECA ABUnited KingdomEP2170848Current

GG-

GP443

Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapyASTRAZENECA ABUnited KingdomEP1824855Current

GG-

GP442

Modulators of pharmacokinetic properties of therapeuticsGILEAD SCIENCES, INC.United KingdomEP2049506Current

GG-

GP441

Prodrugs of phosphonate nucleotide analogues and methods for selecting and making sameGILEAD SCIENCES, INC.United KingdomEP1301519Current

GG-

GP440

SUBSTITUTED CINNOLINE DERIVATIVES AS GABAA-RECEPTOR MODULATORS AND METHOD FOR THEIR SYNTHESISASTRAZENECA ABThe European OfficeEP1966158Current

GG-

GP439

Morpholino pyrimidines and their use in therapyASTRAZENECA ABUnited KingdomEP2579877Current

GG-

GP438

Substituted diazepan compounds as orexin receptor antagonistsMERCK SHARP & DOHME CORP.United KingdomEP2089382Current
GG-GP437Beta-lactamase inhibitorsMERCK SHARP & DOHME CORP.The European Patent Office2666774Current
GG-GP436Relocation in a communication systemVRINGO INFRASTRUCTURE, INC.United KingdomEP1212919Current
GG-GP435Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitorsASTRAZENECA ABUnited KingdomEP2201012Current
GG-GP434Novel hydrogen sulfate salt[1] ARRAY BIOPHARMA, INC. [2] ASTRAZENECA ABThe European Patent OfficeEP1968948Current
GG-GP433Composition for inhibition of cathepsin k[1] Merk Sharp & Dohme Corp & [2] Merck Canada Inc.United Kingdom1855674Current
GG-GP432Heterocyclic compounds that are active as beta lactamase inhibitorsASTRA ZENECA HOLDING FRANCEUnited KingdomUK 2279737Ceased
GG-GP4311-alkoxy 1h-imidazo ring systems and methods3M INNOVATIVE PROPERTIES COMPANYUnited Kingdom1789042Current
GG-GP430Humanized antibodies that recognize beta amyloid peptideJANSSEN SCIENCES IRELAND UC and WYETH LLCUnited KingdomEP1636268Current
GG-GP429Monodisperse pegylated naloxol compositionsNEKTAR THERAPEUTICSUnited KingdomEP1694363Current
GG-GP428Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitorsINCYTE CORPORATIONUnited Kingdom1966202Current
GG-GP427Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLCUnited Kingdom1868645Current
GG-GP426Inhalation device for drugs in powder formAstraZeneca ABUnited Kingdom2063940Current
GG-GP425Antibodies to human Programmed Death ReceptorMerck Sharp & Dohme B.V.United Kingdom2170959Current
GG-GP424Freeze-dried dosage form containing ondansetronGlaxosmithkline Inc.United Kingdom2295318Current
GG-GP423DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVESPfizer Inc.United KingdomEP2334687Current
GG-GP422AMINO-HETEROCYCLIC COMPOUNDSPfizer Inc.United KingdomEP2152712Ceased
GG-GP421PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORSASTRAZENECA ABThe European Patent OfficeEP1809624Current
GG-GP420Oxyntomodulin analogsA) MERCK SHARP & DOHME CORP.  B) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE C) INDIANA UNIVERSITY RESEARCH&TECHNOLOGY CORPORATIONUnited KingdomEP2398483Current
GG-GP419Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME CORP.United KingdomEP2358717Current
GG-GP4184-PHENYLAMINO-QUINAZOLIN-6-YL-AMIDESWARNER-LAMBERT COMPANY LLCUnited KingdomEP1746999Current
GG-GP417N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives as lxr modulatorsMERCK SHARP & DOHME B.V.United KingdomEP2297118Current
GG-GP416Pyrido-, pyrazo- and pyrimidopyrimidine derivatives as mTOR inhibitorsKuDOS PHARMACEUTICALS LTDUnited KingdomEP1954699Current
GG-GP4158a-azalides as veterinary antimicrobial agentsMERCK SHARP & DOHME CORP.The European Patent Office1510214Current
GG-GP414Anacetrapib and other cetp inhibitprsMERCK SHARP & DOHME CORP.The European Patent Office1765793Current
GG-GP413LIVE ATTENUATED ROTAVIRUS VACCINE FOR ORAL ADMINISTRATIONGLAXOSMITHKLINE BIOLOGICALS S.A.The European Patent Office1863526Current
GG-GP412Tricyclic compounds and their use as glucocorticoid receptor modulatorsPfizer Products Inc.The European Patent Office2114970Current
GG-GP411STABILIZED PHARMACEUTICAL COMPOSITIONS COMPRISING FESOTERODINEUCB PHARMA GMBHThe European Patent Office2029134Current
GG-GP410New crystalline and amorphous form of a triazolo (4,5-D)pyrimidine compoundAstrazeneca ABThe European Patent Office1493745Current
GG-GP409Screed comprising recycled glass wasteEcoscreed Holdings LimitedThe European Patent OfficeEP 1 622847Current
GG-GP408A method of laying a floor covering!OBAC LimitedThe European Patent OfficeEP1768527Current
GG-GP4073-aminocyclopentanecarboxamides as chemokine receptor modulatorsPfizer IncThe European Patent OfficeEP2370442Current
GG-GP406Pharmaceutical composition 271A) Astrazeneca AB    B) Array Biopharma, Inc.The European Patent OfficeEP2271321Current
GG-GP405Tricyclic compounds and their use as glucocorticoid receptor modulatorsPfizer Products Inc.The European Patent OfficeEP2114888Current
GG-GP404Therapeutic formulation for administering tolterodine with controlled releasePfizer Health ABThe European Patent OfficeEP1039882Current
GG-GP403Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitorsPfizer Inc.The European Patent OfficeEP1784396Current
GG-GP402Tricyclic nitrogen containing compounds as antibacterial agents.Glaxo Group LimitedThe European Patent OfficeEP2137196Current
GG-GP4015-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORSPANMIRA PHARMACEUTICALS,LLCThe European Patent Office1943219Ceased
GG-GP400Use of mammalian cytokine-related reagentsMERCK SHARP & DOHME CORPThe European Patent Office2311869Current
GG-GP399(2S,3R)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3 YL) BENZOFURAN-2-CARBOXAMIDE, NOVEL SALT FORMS, AND METHODS OF USE THEREOFTARGACEPT, INCThe European Patent OfficeEP 2 182 949Current
GG-GP3985,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibiting activityPfizer LimitedThe European Patent OfficeEP 1 689 751Current
GG-GP397Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising themPFIZER ITALIA S.R.L.United KingdomEP1320531Ceased
GG-GP396Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitorsA) Merck Sharp & Dohme Corp B) MSD Italia S.R.LThe European Patent OfficeEP 2 310 095Current
GG-GP395Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulatorsMERCK SHARP & DOHME CORPThe European Patent OfficeEP 2 358 686Current
GG-GP394ACYLAMINOPYRAZOLES AS FGFR INHIBITORSASTRAZENECA ABThe European Patent OfficeEP 2 125 748Current
GG-GP393Underwater power generatorRotech Holdings LimitedThe European Patent OfficeEP 2 122 160Current
GG-GP392BICYCLIC HETEROARYL COMPOUNDSARIAD PHARMACEUTICALS, INC.The European Patent OfficeEP 1 973 545Current
GG-GP391HETEROAROMATIC QUINOLINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORSPfizer Products IncThe European Patent OfficeEP 1 841757Current
GG-GP390QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORSARRAY BIOPHARMA, INCThe European Patent OfficeEP 1 660 090Current
GG-GP389ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORSPFIZER, INC.The European Patent OfficeEP 1 786 785Current
GG-GP388N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORSARRAY BIOPHARMA, INC.The European Patent OfficeEP 1482932B1Current
GG-GP387PYRIDINE CARBOXAMIDES AS  11-BETA-HSD1 INHIBITORSAstraZeneca ABThe European Patent OfficeEP 2086939Ceased
GG-GP386AZOLE AND THIAZOLE DERIVATIVES AND THEIR USEPULMAGEN THERAPEUTICS (SYNERGY) LIMITEDThe European Patent OfficeEP 1 924 570Ceased
GG-GP385NOVEL HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA+LACTAMASESAstra Zeneca Holding France SASThe European Patent OfficeEP 1 480 644 B1Current
GG-GP384PREPARATION OF PREGABALIN AND RELATED COMPOUNDSWARNER-LAMBERT COMPANY LLCThe European Patent OfficeEP 1 831 154Current
GG-GP383Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS, INC.The European Patent OfficeEP1856135Ceased
GG-GP382Time-based modelingBrixx International LimitedUnited States Of America6360188Current
GG-GP381SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASEPharmacia CorporationThe European Patent OfficeEP 1490064Current
GG-GP380HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTSMerck Sharp & Dohme CorpThe European Patent OfficeEP 2276756Current
GG-GP379STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINESUCB Pharma GmbHThe European Patent OfficeEP1230209Current
GG-GP378METHOD FOR ENZYMATIC PREPARATION OF (S) - 3 - CYANO -5 - METHYLHEXANOIC ACIDPfizer Products Inc.The European Patent OfficeEP1745136Current
GG-GP377QUINICLIDINE DERIVATIVES OF (HETERO) ARYLCYCLOHEPTANECARBOXYLIC ACID AS MUSCARINIC RECEPTOR ANTAGONISTSASTRAZENECA ABUnited Kingdom2094694Ceased
GG-GP376PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)DERIVATIVE USED AS PDE5 INHIBITORSPFIZER PRODUCTS INCThe European Patent OfficeEP1948661Current
GG-GP3755,7-DIAMINOPYRAZOLO¬4,3-D PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSIONa) PFIZER LIMITED          b) PFIZER INC.The European Patent OfficeEP1620437Current
GG-GP3744 - Anilno Quinazoline Derivatives AS Antiproliferative AgentsAstraZeneca ABThe European Patent OfficeEP 1 487 806Current
GG-GP373POWER GENERATING APPARATUS WITH WATER TURBINE WITH BI-SYMMETRIC AIRFOILRotech Holdings LimitedUnited KingdomEP1886015BCurrent
GG-GP3721-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE HYDRAZINO -2'-HYDROXY- 1,1'-BIPHENYL -3-CARBOXYLIC ACIDSMITHKLINE BEECHAM CORPORATIONThe European Patent OfficeEP1534390Current
GG-GP371AN ANTIBODY SPECIFIC FOR SOLUBLE BAFF FOR USE IN THE TREATMENT OF CANCERBIOGEN IDEC MA INCThe European Patent OfficeEP1415659Ceased
GG-GP370CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTSPFIZER LIMITEDThe European Patent OfficeEP1928821Current
GG-GP369POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORSMerck Sharp & Dohme CorpThe European Patent OfficeEP1966151B1Ceased
GG-GP367Neuromuscular Blocking agentsTHE WELLCOME FOUNDATION LIMITEDUnited KingdomGB2 260 763 BExpired
GG-GP366A NOVEL POLYMORPHIC CRYSTALLINE FORM OF FLUTICASONE PROPIONATE, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THEREOFGLAXO GROUP LIMITEDThe European Patent OfficeEP 0 937 100 B1Ceased
GG-GP365METERED DOSE INHALER FOR SALMETEROLSMITHKLINE BEECHAM CORPORTATIONThe European Patent OfficeEP 0 820 323 B1Revoked
GG-GP364CRYSTALLINE R-(R*R*)]-2(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN)WARNER-LAMBERT COMPANYThe European Patent OfficeEP 0 848 705 B1Revoked
GG-GP363USE OF ACTIVITY INHIBITING DIPETIDYL PEPTIDASE IV EFFECTORS FOR LOWERING THE BLOOD GLUCOSE LEVEL IN MAMMALSPROSIDION LIMITEDThe European Patent OfficeEP 0 896 538 B1Revoked
GG-GP362NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS [R- (R*,R*)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1)WARNER-LAMBERT COMPANYThe European Patent OfficeEP 0 839 132 B1Revoked
GG-GP361METHOD FOR PREVENTING OR DELAYING CATHERTER-BASED REVASCULARIZATIONWARNER-LAMBERT COMPANY LLCThe European Patent OfficeEP 1 117 392 B1Revoked
GG-GP360(R-(R*,R*)) - 2 - (4 - FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYL-ETHYL-3-PHENYL-4-((PHENYLAMINO)-CARBONYL)-1H-PYRROLE-1-HEPTANOIC ACID, ITS LACTONE FORM AND SALTS THEREOFWARNER-LAMBERT COMPANYThe European Patent OfficeEP 0 409 281 B1Revoked
GG-GP359Modafinil composition of defined particle sizeCephalon, Inc.United KingdomGB 2 293 103 BRevoked
GG-GP3587-(2-AMINOETHYL)-BENZOTHIAZOLONESASTRAZENECA ABThe European Patent OfficeEP 0649418B1Ceased
GG-GP3571,2,5,6-Tetrahydropyridine-3-Carboxaldehyde Oxime Derivatives, process for their preparation, compositions containing them and their use as medicinesROUSSEL-UCLAFThe European Patent OfficeEP 0 239 445 B1Ceased
GG-GP356VALACICLOVIR TABLETS CONTAINING COLLOIDAL SILICON DIOXIDETHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 806 943 B1Ceased
GG-GP355Medicaments for treating Gastrointestinal disordersGLAXO GROUP LIMITEDUnited KingdomGB 2259647Ceased
GG-GP354Process for preparing aryl-piperidine CarbinolsBEECHAM GROUP PLCThe European Patent OfficeEP 0 300 617 B1Ceased
GG-GP353INDOLE DERIVATIVESGLAXO SpAUnited KingdomGB2 266 091Ceased
GG-GP352Pharmaceutical compositions containing furan derivativesGLAXO GROUP LIMITEDUnited KingdomGB 2 248 185 BCeased
GG-GP351Attendance registration system by radio linkALI GURYELThe European Patent OfficeEP 0 664 061 B1Ceased
GG-GP350Film-coated solid dosage form of anti-migraine drugGLAXO GROUP LIMITEDUnited KingdomGB 2 254 784 BCeased
GG-GP349Preparation of Clavulanic AcidSMITHKLINE BEECHAM PLCUnited KingdomGB 2 287 026BCeased
GG-GP348Window Restricting DeviceSECURISTYLE LIMITEDUnited KingdomGB 2246393 BCeased
GG-GP347Recombinant 21 KD Cocoa Protein and PrecursorMARS UK LIMITEDUnited KingdomGB 2260327Ceased
GG-GP34647kD and 31 kD cocoa bean proteins and a 67 kD precursor thereforMARS UK LIMITEDUnited KingdomGB 2260328Ceased
GG-GP345Improvements in claddingSOLAGLAS LIMITEDUnited KingdomGB 2227270 BCeased
GG-GP344Pyrazolopyrimidinones for the treatment of impotencePFIZER LIMITEDThe European Patent OfficeEP 0 702 555 B1Revoked
GG-GP343USE OF MOMETASONE FLOURATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASESMerck Sharp & Dohme CorpThe European Patent OfficeEP 2 156 840 B1Ceased
GG-GP342DISC TUMBLER CYLINDER LOCK AND KEY COMBINATIONABLOY OYThe European Patent OfficeEP 2 029 839 B1Current
GG-GP341TRIAZOLOPYRIDINYLSULFANYL DERIVATIVES AS P38 MAP KINASE INHIBITORSPFIZER LIMITEDThe European Patent OfficeEP 1 778 686 B9Current
GG-GP340TETRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERES THEREOFMERCK SHARP & DOHME CORPThe European Patent OfficeEP 1 599 469 B1Ceased
GG-GP339N-ARYL DIAZASPIRACYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOFTARGACEPT INCThe European Patent OfficeEP 1 519 939 B9Ceased
GG-GP338USE OF MOMETASONE FLOURATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASESMerck Sharp & Dohme CorpThe European Patent OfficeEP 1 174 138 B1Ceased
GG-GP336ANDROSTENONE DERIVATIVEGLAXO WELLCOME INC.The European Patent OfficeEP 0 719 278 B1Expired
GG-GP335Electrode StructureFORCE TECHNOLOGYUnited KingdomGB 2306973Ceased
GG-GP334SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTSMerck Sharp & Dohme CorpThe European Patent OfficeEP 1 347 987 B1Current
GG-GP333SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTSMerck Sharp & Dohme CorpThe European Patent OfficeEP 0 877 750 B1Ceased
GG-GP332ANIMAL ACCESS SYSTEMDAVID CHAMBERLAINUnited KingdomGB 2 381 180 BCeased
GG-GP331SLIDING SASH WINDOWSVENTROLLA LIMITEDUnited KingdomGB2276904Ceased
GG-GP329THF-CONTAINING SULFONADE INHIBITORS OF ASPARTYL PROTEASEVERTEX PHARMACEUTICALS INCORPORATEDThe European Patent OfficeEP 0 846 110 B1Current
GG-GP328CARBOCYCLIC NUCLEOSIDE HEMISULFATE AND ITS USE IN TREATING VIRAL INFECTIONSGLAXO GROUP LIMITEDUnited KingdomGB 2 340 491Current
GG-GP327HYDROXY-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTSMerck Sharp & Dohme CorpThe European Patent OfficeEP 0 720 599 B1Expired
GG-GP326LIQUID COMPOSITION CONTAINING ONDANSETRONGLAXOSMITHKLINE INC.United KingdomGB 2295317BCurrent
GG-GP325METHOD OF TREATING ANDROGENIC ALOPECIA WITH 5-ALPHA REDUCTASTE INHIBITORSMerck Sharp & Dohme CorpThe European Patent OfficeEP 0 724 444 B1Expired
GG-GP324ELECTROCHEMICAL TREATMENT OF REINFORCED CONCRETEATRAVERDA LIMITEDThe European Patent OfficeEP 1 055 017 B1Ceased
GG-GP323Modafinil having defined particle sizeCephalon, Inc.The European Patent OfficeEP0731698 B1Ceased
GG-GP322SASH WINDOW PARTING BEADSVENTROLLA LIMITEDUnited KingdomGB2314578Ceased
GG-GP321IMPROVEMENTS IN OR RELATING TO BEVERAGESROBINSONS SOFT DRINKS LIMITEDUnited KingdomGB2312606 BCeased
GG-GP320IMPROVEMENTS IN OR RELATING TO BEVERAGESROBINSONS SOFT DRINKS LIMITEDUnited KingdomGB2298350 BCeased
GG-GP319Synthesis of n-acetyl neuraminic acid derivativesBIOTA SCIENTIFIC PTY LTDThe European Patent OfficeEP 0 662 967 B1Expired
GG-GP318Plastics pipingHEPWORTH BUILDING PRODUCTS LIMITEDUnited KingdomGB2289108Ceased
GG-GP317PYRIMIDINE DERIVATIVES AS HMG-COA REDUCTASE INHIBITORSSHIONOGI SEIYAKU KABUSHIKI KAISHAThe European Patent OfficeEP 0 521 471 B1Current
GG-GP316CARBAPENEMS CONTAINING A CARBOXY SUBSTITUTED PHENYL GROUP, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND USE AS ANTIBIOTICSASTRA ZENECA ABThe European Patent OfficeEP 0 579 826 B1Expired
GG-GP315PRODRUGS OF THROMBIN INHIBITORSASTRAZENECA ABThe European Patent OfficeEP 0 995 755 B1Ceased
GG-GP314Stable Oral CI-981 Formulation and Process of preparing sameWARNER-LAMBERT COMPANYThe European Patent OfficeEP 0680 320 B1Ceased
GG-GP313ELECTROCHEMICAL METHOD AND ELECTRODEATRAVERDA LIMITEDThe European Patent OfficeEP 0 883 700 B1Ceased
GG-GP312CRYSTALLINE N-ACETYL NEURAMINIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATIONBIOTA SCIENTIFIC PTY LTDThe European Patent OfficeEP 0734382 B1Expired
GG-GP311SLOT DRAINALUMASC LIMITEDUnited KingdomGB2388144BCeased
GG-GP310Detection of multiple articlesBTG INTERNATIONAL LIMITEDThe European Patent OfficeEP 0598624Ceased
GG-GP309FLUTICASONE PROPIONATE FORMULATIONSGLAXO WELLCOME AUSTRALIA LTDThe European Patent OfficeEP 0 760 649 B1Expired
GG-GP308MEDICAMENTSGLAXO GROUP LIMITEDThe European Patent OfficeEP 0 616 523 B1Ceased
GG-GP307COMBINATION OF ATOVAQUONE WITH PROGUANIL FOR THE TREATMENT OF PROTOZOAL INFECTIONSTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 670 719 B1Expired
GG-GP306Transmission networkNORWEB PLCUnited KingdomGB2 272 350Ceased
GG-GP305Transmission network and filter thereforNORWEB PLCUnited KingdomGB2 304 013Ceased
GG-GP304QUINAZOLINE DERIVATIVESAstrazeneca ABThe European Patent OfficeEP 0 823 900Ceased
GG-GP303N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTSASTRAZENECA ABThe European Patent OfficeEP 0 832 082 B1Ceased
GG-GP302NITRIC OXIDE SYNTHASE INHIBITORSGLAXO GROUP LIMITEDThe European Patent OfficeEP 0 958 277 B1Ceased
GG-GP301AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORSTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 618 898 B1Ceased
GG-GP300Modafinil having defined particle sizeCephalon, Inc.The European Patent OfficeEP 0 966962 B1Ceased
GG-GP299Advertising FittingESCALATOR ADVERTISING LIMITEDUnited KingdomGB2269150Ceased
GG-GP298SULFONAMIDE INHIBITORS OF HIV-ASPARTYL PROTEASEVERTEX PHARMACEUTICALS INCORPORATEDThe European Patent OfficeEP 0 659 181 B1Expired
GG-GP297FREEZE-DRIED DOSAGE FORM CONTAINING ONDANSETRONGLAXO WELLCOME INC.United KingdomGB2295318BCeased
GG-GP296CRYSTALLINE FORMS OF Et02C-CH2-(R)Cgl-Aze-Pab-OHASTRAZENECA ABThe European Patent OfficeEP 1 107 980 B1Ceased
GG-GP295SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVESSMITHKLINE BEECHAM PLCThe European Patent OfficeEP 0 658 161 B1Ceased
GG-GP294CORD LOCKING DEVICES AND SASH WINDOW PARTING BEADSVENTROLLA LIMITEDUnited KingdomGB2298892Ceased
GG-GP293PAROXETINE HYDROCHLORIDE ANHYDRATE SUBSTANTIALLY FREE OF BOUND ORGANIC SOLVENTSMITHKLINE BEECHAM PLCUnited KingdomGB 2 297 550 BCeased
GG-GP291ONDANSETRON FOR RECTAL ADMINISTRATIONLABORATORIES GLAXO SAUnited KingdomGB2279008BCeased
GG-GP290Substituted Pyrazolyl Benzenesulfonamides for the treatment of inflammationG.D. SEARLE & COThe European Patent OfficeEP 0 731 795 B1Expired
GG-GP289SUSTAINED RELEASE TABLETS CONTAINING BUPROPIONTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 656 775 B1Ceased
GG-GP288Magnifying SpectaclesMARJORIE ANNE MOYSEUnited KingdomGB 2317966Ceased
GG-GP287Process for the preparation of N-Acetyl Neuraminic Acid DerivativesBIOTA SCIENTIFIC PTY LTDThe European Patent OfficeEP 0 705 256 B1Expired
GG-GP286QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORSASTRAZENECA ABThe European Patent OfficeEP 1 154 774 B1Current
GG-GP285PYRROLO 2,3-d] PYRIMIDINE COMPOUNDSPFIZER PRODUCTS INCThe European Patent OfficeEP 1 087 971 B1Ceased
GG-GP284ISOTHIAZOLE DERIVATIVES USEFUL AS ANTICANCER AGENTSPFIZER PRODUCTS INCThe European Patent OfficeEP 1 084 114 B1Ceased
GG-GP283VACCINE AGAINST HUMAN PAPILLOMAVIRUS (TYPES 18)UNIVERSITY OF QUEENSLANDThe European Patent OfficeEP 1359 156 B1Expired
GG-GP282TRIAZOLYL TROPANE DERICATIVES AS CCR5 MODULATORSPFIZER LIMITEDThe European Patent OfficeEP 1 284 974 B1Current
GG-GP281TRICYCLIC INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASESAGOURON PHARMACEUTICALS INCThe European Patent OfficeEP 1 140 936 B1Ceased
GG-GP280ASYMMETRIC SYNTHESIS OF PREGABALINWARNER-LAMBERT COMPANY LLCThe European Patent OfficeEP 1 250 311 B1Ceased
GG-GP279PYRROLO 2,3-d] PYRIMIDINE COMOUNDSPFIZER PRODUCTS INCThe European Patent OfficeEP 1 087 970 B1Ceased
GG-GP278IMPROVEMENTS IN OR RELATING TO BEVERAGESROBISONS SOFT DRINKS LIMITEDUnited KingdomGB 2 312 606 BCeased
GG-GP277IMPROVEMENTS IN OR RELATING TO BEVERAGESROBISONS SOFT DRINKS LIMITEDUnited KingdomGB 2 298 350 BCeased
GG-GP276ADAMANTANE DERIVATIVESASTRAZENECA ABThe European Patent OfficeEP 1 242 364 B1Ceased
GG-GP275INK CARTRIDGE FOR INK-JET PRINTING APPARATUSSEIKO EPSON CORPORATIONUnited KingdomGB 2 369 801 BCurrent
GG-GP274INK TANK CATRIDGE AND CONTAINER THEREFORSeiko Epson CorportationThe European Patent OfficeEP 0 553 535 B2Expired
GG-GP273INK TANK CATRIDGE AND CONTAINER THEREFORSeiko Epson CorportationThe European Patent OfficeEP 1 013 444 B1Expired
GG-GP272INK SUPPLY UNITSeiko Epson CorporationThe European Patent OfficeEP 1 016 533 B1Current
GG-GP271INK CATRIDGE AND RECORDING APPARATUSSeiko Epson CorporationUnited KingdomGB 2 395 684 BCurrent
GG-GP270INK CATRIDGE AND INK-JET RECORDING APPARATUSSeiko Epson CorporationThe European Patent OfficeEP 1 247 650 B1Ceased
GG-GP269NOVEL TRIAZOLO(4,5-D)PYRIMIDINE COMPOUNDSASTRAZENECA ABThe European Patent OfficeEP 1 135 391 B1Current
GG-GP268PHOSPHODIESTRERASE INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTIONLILLY Icos LLCThe European Patent OfficeEP 1 173 181 B1Current
GG-GP267INCLUSION COMPLEXES OF ARYL-HETEROCYCLIC SALTSPFIZER INCThe European Patent OfficeEP 0 900 088 B1Current
GG-GP266PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORSPFIZER PRODUCTS INCThe European Patent OfficeEP 1 235 830 B1Current
GG-GP265STRUCTURE AND METHOD FOR JOINING PARTSPFIZER HEALTH ABThe European Patent OfficeEP 0 965 002B1Current
GG-GP264ACRIDINE DERIVATIVE FOR INCREASING THE BIOAVAILABILITY OF TAXOLGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 009 436 B1Ceased
GG-GP263NEW FORMULATION FOR INHILATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, A PROCESS FOR PREPARING THE FORMULATION AND USE THEREOFASTRAZENECA ABThe European Patent OfficeEP 1 007 017 B1Current
GG-GP262NEW FORMULATION FOR INHILATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, COMPRISING FORMOTEROLASTRAZENECA ABThe European Patent OfficeEP 1 009 394 B1Current
GG-GP261QUINOLINE DERIVATIVES AS TACHYKININ NK3 RECEPTOR ANTAGONISTSSMITHKLINE BEECHAM FARMACEUTICI S.p.A.The European Patent OfficeEP 0 804 419 B1Ceased
GG-GP259THIAZOLIDINEDIONE DERIVATIVE AND ITS USE AS ANTIDIABETICSMITHKLINE BEECHAM PLCThe European Patent OfficeEP 1 173 434 B1Ceased
GG-GP2582, 3-DIARYL-PYRAZOLO (1,5-B) PYRIDAZINES DERIVATIVES, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORSGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 032 575 B1Ceased
GG-GP257FORMULATIONASTRAZENECA ABUnited KingdomGB 2 359 254 BCurrent
GG-GP256Swallow Tablet Comprising ParacetamolGLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO.2)The European Patent OfficeEP 0 981 334 B1Current
GG-GP255Quinoline Derivatives as NK3 AntagonistsGlaxoSmithKline S.p.AThe European Patent OfficeEP 0 874 827 B1Ceased
GG-GP254Process for the Synthesis of HIV Protease InhibitorsGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 066 276 B1Ceased
GG-GP253GAMES AND GAME APPARATUSDEREK JOHN WEBB and HANNAH SARAH O'DONNELL in partnership as Prime Table Games UKUnited KingdomGB 2291360 BCeased
GG-GP252BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORSGlaxoSmithKline LLCThe European Patent OfficeEP 1 047 694 B1Current
GG-GP251CHEMICAL COMPOUNDSGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 098 898 B1Current
GG-GP248METHOD FOR REMOVING SURFACE COATINGSFARROW SYSTEM LLIMITEDUnited KingdomGB 2 344 348Ceased
GG-GP247EXO-S-MECAMYLAMINE FORMULATIONUNIVERSITY OF SOUTH FLORIDAThe European Patent OfficeEP 1 634 498 B1Current
GG-GP246TRIAZOLYL TROPANE DERICATIVES AS CCR5 MODULATORSPFIZER LIMITEDThe European Patent OfficeEP 1 526 134 B1Current
GG-GP2451,2,3,4-TETRASUBSTITUTED INDOLE FOR THE TREATMENT OF RESPIRATORY DISEASESASTRAZENECA ABThe European Patent OfficeEP 1 656 346 B1Ceased
GG-GP244PYRAZOLE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASESASTRAZENECA ABThe European Patent OfficeEP 1 686 999 B1Current
GG-GP243REDUCTION OF DIZZINESS, A SIDE EFFECT ASSOCIATED WITH PIRFENIDONE THERAPYINTERMUNE, INCThe European Patent OfficeEP 1 965 797 B1Current
GG-GP242NICOTINIC ACETYLCHOLINE RECEPTORSUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANESTARGACEPT INCThe European Patent OfficeEP 2 094 703 B1Current
GG-GP241ARYLVINYLAZACYCLOALKANE COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOFTARGACEPT INCThe European Patent OfficeEP 2 085 395 B1Ceased
GG-GP240IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERSPFIZER PRODUCTS INCThe European Patent OfficeEP 1 730 119 B1Current
GG-GP239TRICYCLIC THROMBIN RECEPTOR ANTAGONISTSCHERING CORPORATIONThe European Patent OfficeEP 2 062 890 B1Current
GG-GP238USE OF R- (+) -2-(3-DIISOPROYLAMINO-1-PHENYLPROPYL) -4-HYDROXY-METHYL-PHENYLISOBUTY RIC ACID ESTER HYDROGENFUMARATE FOR THE TREATMENT OF URINARY INCONTINENCEUCB PHARMA GMBHThe European Patent OfficeEP 1 690 536 B1Current
GG-GP237QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE ReceptorsGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 646 613 B1Ceased
GG-GP235VACCINE AGAINST ANTIGENS FROM BACTERIAEGLAXOSMITHKLINE BOLOGICALS S.A.The European Patent OfficeEP 1 163 000 B1Ceased
GG-GP2346.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACIDS-FLUOROMETHYL ESTER AS AN ANTI_INFLAMMATORY AGENT.GLAXO GROUP LIMITEDThe European Patent OfficeEP 1 305 329 B1Current
GG-GP233ARYL FUSED AZAPOLYCYCLIC COMPOUNDSPFIZER PRODUCTS INCThe European Patent OfficeEP 1 044 189 B1Current
GG-GP232PHARAMACEUTICAL COMPOSITION CONTANING PROTON PUMP INHIBITORSMerck Sharp & Dohme CorpThe European Patent OfficeEP 0 819 004 B1Ceased
GG-GP231USE OF ROSUVASTATIN (ZD-4522) IN THE TREATMENT OF HETEROZYGOUS FAMILIALHYPERCHOLESTEROLEMIAASTRAZENECA ABThe European Patent OfficeEP 1 339 409 B1Current
GG-GP230PHENETHANOLAMINE DERIVATIVES FOR TREATMENT OF RESPIRATORY DISEASESGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 425 001 B1Current
GG-GP229VACCINES AGAINST CANCERSGLAXOSMITHKLINE BOLOGICALS S.A.The European Patent OfficeEP 1 326 638 B1Current
GG-GP228HCV NS3 PROTEASE INHIBITORSMerck Sharp & Dohme CorpThe European Patent OfficeEP 1 924 593 B1Ceased
GG-GP227Medical use of tetrahydrotriazolo[4.3-a]pyrazineMerck Sharp & Dohme CorpThe European Patent OfficeEP 1 625 847 B1Ceased
GG-GP226ANTIBODIES AGAINST AMYLOID-BETA PEPTIDEGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 996 621 B1Ceased
GG-GP225THROMBOPOIETIN MIMETICSGLAXOSMITHKLINE LLCThe European Patent OfficeEP 1 294 378 B1Current
GG-GP224INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTIEN KINASES, AND METHODS FOR THEIR USEAGOURON PHARMACEUTICALS, INCThe European Patent OfficeEP 1 218 348 B1Current
GG-GP223IMIDAZOPYRIDINE SUBSTITUTED TROPANE DERIVATIVES WITH CCR5 RECEOTIR ANTAGONIST ACTIVITY FOR THE TREATMENT OF HIV AND INFLAMATIONPFIZER LIMITEDThe European Patent OfficeEP 1 682 545 B1Current
GG-GP222SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASESPFIZER PRODUCTS INCThe European Patent OfficeEP 1 708 991 B1Ceased
GG-GP221Compositions containing pyrrolo -2,3-d pryrimidine derivativesPFIZER PRODUCTS INCThe European Patent OfficeEP 1 382 339 B1Current
GG-GP220PYRROLE SUBSTITUED 2-INDOLINONE PROTEIN KINASE INHIBITORSa) PHARMACIA & UPJOHN COMPANY LLC   b) Sugen, Inc.The European Patent OfficeEP 1 255 752 B1Current
GG-GP219SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASESPFIZER LIMITEDThe European Patent OfficeEP 1 708 992 B1Ceased
GG-GP218EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENTUNIVERSITY OF SOUTH FLORIDAThe European Patent OfficeEP 1 139 743 B1Ceased
GG-GP217POWER GENERATOR AND TURBINE UNITROTECH HOLDINGS LIMITEDThe European Patent OfficeEP 1 436 504 B1Current
GG-GP216UNDERWATER POWER GENERATORROTECH HOLDINGS LIMITEDUnited KingdomGB 2447514 BCurrent
GG-GP215N-ARYL DIAZASPIRACYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOFTARGACEPT INCThe European Patent OfficeEP 1 519 939 B1Ceased
GG-GP214PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CENTERAL NERVOS SYSTEM DISORDERS COMPRISING A NICOTINE ANALOG AND AN ACTYLCHOLINESTERASE INHIBITORTARGACEPT INCThe European Patent OfficeEP 1 102 588 B1Ceased
GG-GP213AZABICYCLIC COMPOUNDS FOR RELIEVING PAIN AND TREATING CENTRAL NERVOUS SYSTEM DISORDERSTARGACEPT INCThe European Patent OfficeEP 1 678 172 B1Ceased
GG-GP2123-Substituted-2 (Arylalkyl)-1-Azabicycloalka and methods of use thereofTARGACEPT INCThe European Patent OfficeEP 1 594 869 B9Ceased
GG-GP211ARYLVINYLAZACYCLOALKANE COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOFTARGACEPT INCThe European Patent OfficeEP 1 601 670 B1Current
GG-GP210Adjuvant systems and vaccinesGLAXOSMITHKLINE BIOLOGICALS S.A.The European Patent OfficeEP 1 126 876 B1Ceased
GG-GP209PYRAZOLE DERIVATIVES FOR TREATING HIVPFIZER LIMITEDThe European Patent OfficeEP 1 377 556 B1Current
GG-GP208IMMUNOSTIMULATORY NUCLEIC ACIDSUNIVERSITY OF IOWA RESEARCH FOUNDATIONThe European Patent OfficeEP 1 221 955Ceased
GG-GP207LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORSBRISTOL-MYERS SQUIBB COMPANYThe European Patent OfficeEP 1 427 415 B1Current
GG-GP206QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDSAxovant Sciences Ltd.The European Patent OfficeEP 1 497 266 B1Current
GG-GP204INFLUENZA VACCINE COMPOSITIONGLAXOSMITHKLINE BIOLOGICALS NIEDERLASSUNG DER SMITHKLINE BEECHAM PHARMA GmbH & CO. KGThe European Patent OfficeEP 1 407 008 B1Ceased
GG-GP203PHENYLACETAMIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTSPFIZER ITALIA S.R.L.The European Patent OfficeEP 1 406 899 B1Ceased
GG-GP202NEW MODULATORS OF DOPAMINE NEUROTRANSMISSIONTEVA PHARMACEUTICALS INTERNATIONAL GMBHThe European Patent OfficeEP 1 240 142 B1Current
GG-GP201USE OF AN ANTAGONIST ANTIBODY TO THE INFLAMMATORY MEDIATOR ONCOSTATIN M (OSM)GLAXO GROUP LIMITEDThe European Patent OfficeEP 1 071 449 B1Ceased
GG-GP200PYRIMIDINE-4-ONE DERIVATIVE AS LDL-PLA2 INHIBITORSmithkline Beecham PLCThe European Patent OfficeEP 1 263 740 B1Current
GG-GP199INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADEWARNER-LAMBERT COMPANY LLCThe European Patent OfficeEP 1 465 864 B1Ceased
GG-GP198(S, S)-REBOXETINE FOR TREATING CHRONIC PAINPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 196 172 B1Ceased
GG-GP197HIGH DRUG LOAD TABLETNOVARTIS AG, Incorporated in SwitzerlandThe European Patent OfficeEP 1 501 485 B1Ceased
GG-GP196INHIBITORS OF TYROSINE KINASESNOVARTIS AG, Incorporated in SwitzerlandThe European Patent OfficeEP 1 532 138 B1Current
GG-GP195C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHODAstraZeneca ABThe European Patent OfficeEP 1 506 211 B1Current
GG-GP194NEW FORMULATIONASTRAZENECA ABThe European Patent OfficeEP 1 000 079 B1Current
GG-GP193WINDANGETRIEBENES WASSERFAHRZEUGSKYSAILS GMBH & CO., KGThe European Patent OfficeEP 1 409 339 B1Ceased
GG-GP192THERAPEUTIC COMBINATIONS COMPRISING AMLODIPINE AND ATORVASTATINPFIZER PRODUCTS INCThe European Patent OfficeEP 1 491 193 B1Ceased
GG-GP190CYCLIC AMINO ACIDS AND DERIVATIVES THEREOF USEFUL AS PHARMACEUTICAL AGENTSWARNER-LAMBERT COMPANY LLCThe European Patent OfficeEP 1 032 555 B1Ceased
GG-GP189UNDERWATER DUCTED TURBINECLEAN CURRENT LIMITED PARTENERSHIPThe European Patent OfficeEP 1 430 220B1Ceased
GG-GP188IMMUNOSTIMULATORY NUCLEIC ACIDSUNIVERSITY OF IOWA RESEARCH FOUNDATION and COLEY PHARMACEUTICAL GMBHThe European Patent OfficeEP 1 221 955 B9Ceased
GG-GP187SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETOARENA PHARMACEUTICALS, INC.The European Patent OfficeEP 1 732 562 B1Ceased
GG-GP186VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) NUCLEIC ACID LIGAND COMPLEXESGILEAD SCIENCES, INC.The European Patent OfficeEP 0 957 929 B1Ceased
GG-GP185ROPINIROLE-CONTAINING HYDROPHILIC/LIPHILIC POLYMERIC MATRIX DOSAGE FORMULATIONJAGOTEC AGThe European Patent OfficeEP 1 272 167 B1Ceased
GG-GP184DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHLAXIS AND TREATMENT OF DISORDERS RELATED THERETOARENA PHARMACEUTICALS, INC.The European Patent OfficeEP 1 558 582 B1Current
GG-GP183QUINAZOLINE DERIVATIVES AS VEGF INHIBITORSASTRAZENECA ABThe European Patent OfficeEP 1 244 647 B1Current
GG-GP182THERAPEUTIC BIARYL DERIVATIVESGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 087 943 B1Current
GG-GP180Paving BlockHanson Building Products LimitedUnited KingdomGB 2 338 969 BCurrent
GG-GP179CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO - (N+1) - ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITYPHARMACIA CORPORTATIONThe European Patent OfficeEP 1 115 695Ceased
GG-GP178(S,S) - REBOXETINE FOR TREATING FIBROMYALGIA AND OTHER SOMATOFORM DISORDERSPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 459 750Ceased
GG-GP177Compounds affecting glucokinaseASTRAZENECA ABThe European Patent OfficeEP 1 529 530 B1Ceased
GG-GP176OXIDATION PROCESS FOR PREPARING THE INTERMEDIATE 6.ALPHA.-DIFLURO-11.BETA.,17.ALPHA.-DIHYDROXY-16.ALPHA.-METHYL-ANDROST-1,4-DIEN-3-ONE17.BETA.-CARBOXYLIC ACIDGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 301 526B1Ceased
GG-GP175(S,S) - REBOXETINE FOR TREATING FIBROMYALGIA AND OTHER SOMATOFORM DISORDERSPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 459 750 B1Ceased
GG-GP174THROMBOPOIETIN MIMETICSSMITHKLINE BEECHAM CORPORTATIONThe European Patent OfficeEP 1 294 378 B1Ceased
GG-GP173(R)-CHIRAL HALOGENATED 1- SUBSTITUTEDAMINO-(N+1)- ALKANOLS USEFUL FOR INHIBITING COLESTERYL ESTER TRANSFER PROTEIN ACTIVITYMONSATNO COMPANYThe European Patent OfficeEP 1 115 695 B1Ceased
GG-GP172AMIDINO COMPOUND AND SALTS THEREOF USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORSPHARMACIA CORPORTATIONThe European Patent OfficeEP 1 265 860 B1Ceased
GG-GP171RECONSTITUTABLE PARENERAL COMPOSITION CONTAINING A COX-2 INHIBITORPHARMACIA CORPORTATIONThe European Patent OfficeEP 1 372 645 B1Current
GG-GP170PIPERIDINES FOR USE AS OREXIN RECEPTOR ANTAGONISTSSMITHKLINE BEECHAM PLCThe European Patent OfficeEP 1 289 955 B1Ceased
GG-GP169CHEMICAL COMPOUNDSGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 366 033 B1Ceased
GG-GP168PHTHALAZINONE DERIVATIVESkuDOS Pharmaceuticals LimitedUnited KingdomGB 2 415 430 BCurrent
GG-GP167CRYSTALLINE DERIVATIVES OF 2- (5-CHLOROTHIEN-2-YL) -N- ((3S)-1((1S)-METHYL-2-MORPHOLIN-4-YL)-2-OXOETHYL)-2-OXOPYRROLINDIN-YL) ETHENSULFONAMIDEGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 567 519 B1Ceased
GG-GP166PROCESS FOR PREPARATION OF PYRAZOLO- (4,3-d) PYRIMIDIN-7-ONES AND INTERMEDIATES THEREOFPFIZER LIMITEDThe European Patent OfficeEP 0 994115 B1Ceased
GG-GP165PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HYPERPLASIA AND OTHER DISEASESPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 203 770 B1Expired
GG-GP164STABLE SALTS OF NOVEL DERIVATIVES OF 3, 3-DIPHENYLPROPYLAMINESSCHWARZ PHARAMA AGThe European Patent OfficeEP 1 230 209 B1Ceased
GG-GP163THERAPUTIC COMBINATIONS COMPRISING AMLODIPIN AND ATORVASTATINPFIZER PRODUCTS INCThe European Patent OfficeEP 1 003 503 B1Ceased
GG-GP162NEW AMINOPROPYLPHOSPHINIC ACIDSASTRAZENECA ABThe European Patent OfficeEP 1 240 172 B1Ceased
GG-GP161PIPERAXINE COMPOUNDS AS TACHYKININS ANTAGONISTSGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 218 359 B1Current
GG-GP160PYRAZOLO [4,3-D]PYRIMIDINE DERIVATIVESPFIZER LIMITEDThe European Patent OfficeEP 1 220 856 B1Ceased
GG-GP1595HT2C RECEPTOR MODULATORSARENA PHARMACEUTICALS, INC.The European Patent OfficeEP 1 411 881 B9Ceased
GG-GP158PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORSGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 395 553 B1Ceased
GG-GP157HIV PROTEASE INHIBITORSAGOURON PHARMACEUTICALS INCThe European Patent OfficeEP 0 889 036 B1Expired
GG-GP156Inkjet recording apparatus and inkjet cartridgeSEIKO EPSON CORPORATIONUnited KingdomGB 2 406 544 BCeased
GG-GP155ink cartridge for in jet recording apparatusSEIKO EPSON CORPORATIONThe European Patent OfficeEP 0 715 958 B1Expired
GG-GP154ink cartridge for in jet recording apparatusSEIKO EPSON CORPORATIONThe European Patent OfficeEP 0 516 088 B1Expired
GG-GP153A printing apparatus and ink cartridge thereforeSEIKO EPSON CORPORATIONUnited KingdomGB 2 411 863 BCurrent
GG-GP152Ink cartridge and ink cartridge holderSEIKO EPSON CORPORATIONUnited KingdomGB 2 387 567 BCurrent
GG-GP151A printing apparatus and ink cartridge thereforeSEIKO EPSON CORPORATIONUnited KingdomGB 2 387 353 BCurrent
GG-GP150PLEUROMUTILIN DERIVATIVES AS ANTIMICROBIALSSMITHKLINE BEECHAM PLCThe European Patent OfficeEP 1 028 961 B1Current
GG-GP149CHEMICAL COMPOUNDSGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 326 832 B1Ceased
GG-GP148PROCESS FOR THE PREPARATION OF 3-OXO-4-AZASTEROIDSGLAXO GROUP LIMITEDThe European Patent OfficeEP 1 335 930 B1Ceased
GG-GP147NOVEL METHOD OF TREATMENTSMITHKLINE BEECHAM CORPORATIONThe European Patent OfficeEP 1 135 128 B1Ceased
GG-GP146ADJUVANT COMPOSITION COMPRISING SAPONIN AND AN IMMUNOSTIMULATORY OLIGONCLEOTIDEGLAXOSMITHKLINE BIOLOGIVALS S.A.The European Patent OfficeEP 1 187 629 B1Ceased
GG-GP145NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINESCHWARZ PHARMA AGThe European Patent OfficeEP 1 077 912 B1Current
GG-GP144PRINTER AND INK CARTRIDGE ATTACHED THERETOSEIKO EPSON CORPORATIONThe European Patent OfficeEP 1 004 450 B1Current
GG-GP143INK CATRIDGE ATTACHMENT/DETACHMENT DEVICE, RECORDING APPARATUS, LIQUID INJECTION APPARAUS, AND LIQUID CONTAINERSEIKO EPSON CORPORATIONUnited KingdomGB 2 414 965 BCeased
GG-GP142INK CATRIDGE ATTACHMENT/DETACHMENT DEVICE, RECORDING APPARATUS, LIQUID INJECTION APPARAUS, AND LIQUID CONTAINERSEIKO EPSON CORPORATIONUnited KingdomGB 2 409 435 BCeased
GG-GP141Inkjet recording apparatus and inkjet cartridgeSEIKO EPSON CORPORATIONUnited KingdomGB 2 391 200 BCurrent
GG-GP140INK CARTRIDGE AND PRINTER USING THE SAMESEIKO EPSON CORPORATIONUnited KingdomGB 2 347 649 BCurrent
GG-GP139ANTIVIRAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGSGLAXO GROUP LIMITEDThe European Patent OfficeEP0 513 917 B1Expired
GG-GP138PHARMACEUTICAL COMPOSITIONSNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB 2157686 BCeased
GG-GP137PHARMACEUTICAL COMPOSITIONS CONTAINING 1-HYDROXYPYRID-2-ONE DERIVATIVESNATIONAL RESEARCH DEVELOPMENT CORPORATIONThe European Patent OfficeEP 0 138 420 B1Ceased
GG-GP136OPTICAL TRANSMISSION SYSTEMSTHE PLESSEY COMPANY LIMITEDUnited KingdomGB 2086168 BCeased
GG-GP135PCM COMMUNICATION SYSTEMGEC PLESSEY TELECOMMUNICATIONS LTDUnited KingdomGB2221125 BCeased
GG-GP134DATA PATH PROTECTIONGEC PLESSEY TELECOMMUNICATIONS LTDUnited KingdomGB2220329 BExpired
GG-GP133PCM COMMUNICATION SYSTEMGEC PLESSEY TELECOMMUNICATIONS LTDUnited KingdomGB2229610 BExpired
GG-GP132OPTICAL TRANSMISSION APPARATUSGEC PLESSEY TELECOMMUNICATIONS LTDUnited KingdomGB2233851 BExpired
GG-GP131HETEROCYCLIC DERIVATIVESGLAXO GROUP LIMITEDUnited KingdomGB 2 220 937Expired
GG-GP130ASSEMBLIES OF ELECTRICAL OR ELECTRONIC APPARATUS.THE GENERAL ELECTRIC COMPANY P L CUnited KingdomGB 2100522Ceased
GG-GP129ASSEMBLIES OF ELECTRICAL OR ELECTRONIC APPARATUSTHE GENERAL ELECTRIC COMPANY P L CUnited KingdomGB2100118Ceased
GG-GP128DATA PROCESSING ARRANGEMENTSTHE GENERAL ELECTRIC COMPANY P L CUnited KingdomGB 2099619Ceased
GG-GP127Use of a tetrahydrocarbazolone derivative for the manufacture of medicamentsGLAXO GROUP LIMITEDThe European Patent OfficeEP 0 226 266 B1Expired
GG-GP125TRANSMISSIONS SYSTEMSTHE GENERAL ELECTRIC COMPANY P L CUnited KingdomGB2145608 BExpired
GG-GP124Derivative of a n-phenylpyrazoleRHONE-POULENC AGRICULTURE LIMITEDThe European Patent OfficeEP 0295117Expired
GG-GP123INDOLE DERIVATIVESGLAXO GROUP LIMITEDUnited KingdomGB 2 208 646Expired
GG-GP122NEW METHOD OF TRAFFIC CONTROL AND THE ROAD CONSTRUCTION ON THE CROSS SECTION OF A ROADYANG YIN-LUNGUnited KingdomGB2202562Ceased
GG-GP121ANTIBIOTIC M 139,603 FROM STREPTOMYCES LONGISPOROFLAVUSIMPERIAL CHEMICAL INDUSTRIES PLCUnited KingdomGB 2027013Ceased
GG-GP120MEDICAMENTSGLAXO GROUP LIMITEDUnited KingdomGB 2216414Expired
GG-GP119DRUG ABSORBATESGLAXO GROUP LIMITEDUnited KingdomGB 2218333 BCeased
GG-GP118PHARMACEUTICAL FORMULATION CONTAINING PENCICLOVIRNOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.The European Patent OfficeEP 0 511 991 B1Expired
GG-GP117THERAPEUTIC NUCLEOSIDESTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 434 450 B1Expired
GG-GP116PHARMACOLOGICALLY ACTIVE CNS COMPOUNDSTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 372 934 B1Expired
GG-GP113ELECTRICALLY-PROPELLED VEHICLE WITH INDIVIDUAL WHEEL DRIVEZF FRIEDRICHSHAFEN AKTIENGESELLSCHAFTThe European Patent OfficeEP 1 511 646Ceased
GG-GP112PHARMACEUTICAL COMPOSITIONSNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB 2136807BExpired
GG-GP111Therapeutic heterocyclic compoundsZENECA LIMITEDThe European Patent OfficeEP 0 486 666 B1Expired
GG-GP110MOTORIC DEVICE FOR DIGGING TRENCHES IN THE SOIL WITH THE AID OF ROTARY CUTTERSSOLETANCHE SOCIÉTÉ ANONYME DITEThe European Patent OfficeEP 0 253 726Ceased
GG-GP109Derivatives and analogues of 2-Deoxy-2, 3-Didehydro-N-Acetyl Neuraminic Acid and their use as Antiviral AgentsBIOTA SCIENTIFIC MANAGEMENT PTY LTDThe European Patent OfficeEP 0 526 543 B1Expired
GG-GP108METERING DEVICES AND MAGNETIC CARDS FOR USE WITH SUCH DEVICESGEC TRAFFIC AUTOMATION LIMITEDUnited KingdomGB2157869Expired
GG-GP107MAGNETIC CARD READING DEVICES AND CARDS FOR USE WITH SUCH DEVICESGEC TRAFFIC AUTOMATION LIMITEDUnited KingdomGB2157868Expired
GG-GP106PUMP FOR A DIGGING DEVICE USED FOR DIGGING TRENCHES INTO THE GROUNDSOLETANCHE SOCIÉTÉ ANONYME DITEThe European Patent OfficeEP 0 249 555Ceased
GG-GP103BENZENEDIMETHANOL SUITABLE FOR MICRONISATIONGLAXO GROUP LIMITEDThe European Patent OfficeEP 0 639 176 B1Expired
GG-GP102CEPHALOSPORIN ANTIBIOTICSGLAXO GROUP LIMITEDUnited KingdomGB 2152504 BCeased
GG-GP101PHARMACEUTICAL COMPOSITIONGLAXO GROUP LIMITEDUnited KingdomGB 2 204 792 BExpired
GG-GP98DICHLOROANILINE DERIVATIVESGLAXO GROUP LIMITEDUnited KingdomGB 2187734 BCeased
GG-GP97PHARMACEUTICAL COMPOSITIONSGLAXO CANADA INCUnited KingdomGB 2 229 094 BExpired
GG-GP96IMPROVEMENTS RELATING TO SMOKING ARTICLESBRITISH-AMERICAN TOBACCO COMPANY LIMITEDUnited KingdomGB 2 209 268BExpired
GG-GP95IMPROVEMENTS RELATING TO SMOKING ARTICLESBRITISH-AMERICAN TOBACCO COMPANY LIMITEDUnited KingdomGB 2 209 269 BExpired
GG-GP94CHEMICAL COMPOUNDSGLAXO GROUP LIMITEDUnited KingdomGB 2150932Ceased
GG-GP93PHARMACEUTICAL FORMULATIONFISONS PLCUnited KingdomGB 2187953Ceased
GG-GP92TRANS-6-[2-(3 OR 4 - CARBOXAMIDO-SUBSTITUTED PYRROL-1-YL)-ALKYL]-4-HYDROXYPYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESISWARNER-LAMBERT COMPANYThe European Patent OfficeEP 0247633Expired
GG-GP79Therapeutic heterocyclic compoundsASTRA ZENECA ABThe European Patent OfficeEP0486666Expired
GG-GP78HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONGLAXO SPAUnited KingdomGB 2181127 BCeased
GG-GP77HIGH TOUGHNESS CERAMICS AND PROCESS FOR THE PREPARATION THEREOFHITACHI, LTDThe European Patent OfficeEP 0 188 129 B1Ceased
GG-GP76Water-Dispersible TabletsTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 522 128 B1Expired
GG-GP75Water-Dispersible Tablet containing LamotrigineTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 685 231 B1Expired
GG-GP74PHARMACEUTICAL COMPOSITIONSLABORATOIRES GLAXO S.AUnited KingdomGB2219940Expired
GG-GP72HETEROCYCLIC AMINO COMPOUNDSGLAXO GROUP LIMITEDThe European Patent OfficeEP 0 162 593Ceased
GG-GP71FUNGICIDAL COMPOSITION BASED ON ALUMINIUM TRIS-(ETHYL PHOSPHONATE)RHONE-POULENC AGROCHIMIEUnited KingdomGB 2137498BCeased
GG-GP70TELECOMMUNICATIONS DIGITAL SWITCHBLOCKTHE PLESSEY COMPANYUnknown Jurisdiction2125254Ceased
GG-GP69PHARMACEUTICAL COMPOSITIONSNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB2157686BCeased
GG-GP68PHARMACEUTICAL COMPOSITIONSNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB2146989BCeased
GG-GP67ELECTRONIC DETECTION CIRCUITTHE PLESSEY COMPANY LIMITEDUnited KingdomGB 2072461BCeased
GG-GP66PHARMACEUTICAL COMPOSITIONSNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB 2146989BExpired
GG-GP65Therapeutic nucleosidesTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP0 349 242 B1Expired
GG-GP64MAGNETIC CARD READING DEVICES AND CARDS FOR USE WITH SUCH DEVICESGEC TRAFFIC AUTOMATION LIMITEDUnited KingdomGB 2157868Expired
GG-GP63METERING DEVICES AND MAGNETIC CARDS FOR USE WITH SUCH DEVICESGEC TRAFFIC AUTOMATION LIMITEDUnited KingdomGB 2157869Expired
GG-GP62HETEROCYCLIC AMINO COMPOUNDSGLAXO GROUP LIMITEDUnited KingdomGB 2157691BExpired
GG-GP61LACTAM DERIVATIVESGLAXO GROUP LIMITEDUnited KingdomGB 2209335 BExpired
GG-GP60AMINOCYCLOPENTANOL ACIDS AND ESTERS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONGLAXO GROUP LIMITEDUnited KingdomGB 2097397Ceased
GG-GP59IMPROVEMENTS IN OR RELATING TO METHODS AND APPARATUS FOR THE CONTINUOUS FORMATION OF AN EXTRUDED PRODUCTNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB 2237237BCeased
GG-GP58PHARMACEUTICAL COMPOSITIONSNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnknown JurisdictionGB 2136806BCeased
GG-GP56PROCESS FOR THE STABILISATION OF A SOLID PHARMACEUTICAL COMPOSITION COMPRISING CYCLIC AMINO ACIDSGODECKE AKTIENGESELLSCHAFTThe European Patent OfficeEP 0 414 263 B1Expired
GG-GP55New oxime derivatives of 7-amino-thiazolylacetamido-cephalosporanic acid, process for preparing them and pharmaceutical compositions incorporating themROUSSEL-UCLAFUnited KingdomGB 1 580 621Expired
GG-GP54Crystalline form of the sodium salt of an oxyimino derivative of the 7-aminothiazolylacetamido-cephalosporanic acid, process for its preparation and pharmaceutical compositions containing itROUSSEL-UCLAFThe European Patent OfficeEP 0 001 024 B1Expired
GG-GP53MEDICAMENTSGLAXO GROUP LIMITEDUnited KingdomGB2235627 BRevoked
GG-GP52PIPERIDINYLCYCLOPENTANOL HEPTENOIC ACID SALTGLAXO GROUP LIMITEDUnited KingdomGB2127406Ceased
GG-GP51PROCESS AND APPARATUS FOR PRODUCING GLAZED CERAMIC TILES, AND TILES SO OBTAINEDCERAMICA FILIPPO MARAZZI SPAUnited KingdomGB 2,171,402BCeased
GG-GP50PHARMACEUTICAL COMPOUNDSELI LILLY AND COMPANY LIMITEDThe European Patent OfficeEP 0 454 436 B1Expired
GG-GP49HETEROCYCLIC DERIVATIVESGLAXO SPAUnited KingdomGB2164336BExpired
GG-GP48AN IMPROVED PROCESS FOR THE PREPARATION OF SUBSTITUTED INDOLONE DERIVATIVESSMITH KLINE & FRENCH LABORATORIES LIMITEDThe European Patent OfficeEP 0 526 529 B1Expired
GG-GP47New herbicidal nicotinamide derivativesRHONE-POULENC AGRICULTURE LIMITEDThe European Patent OfficeEP 0053011Expired
GG-GP46SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVESBEECHAM GROUP PLCThe European Patent OfficeEP 0 306 228 B1Expired
GG-GP45LACTAM DERIVATIVESGLAXO GROUP LIMITEDUnited KingdomGB 2209335 CExpired
GG-GP44CRYSTALLINE 4-AMINO-1-HYDROXYBUTYLIDENE-1, 1-BISPHOSPHONIC ACID MONOSODIUM TRIHYDRATE, PROCESS THEREFOR AND COMPOSITIONS AND USE THEREOFMERCK & CO. INC.The European Patent OfficeEP 0 402 152 B1Expired
GG-GP42PHARMACEUTICAL COMPOSITIONSNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB2136806Expired
GG-GP413-HYDROXYPRYND-2AND-4-ONESNATIONAL RESEARCH DEVELOPMENT CORPORATIONUnited KingdomGB2136807Expired
GG-GP40PHARMACEUTICAL COMPOSITIONS CONTAINING 1-HYDROXYPYRID-2-ONE DERIVATIVESNATIONAL RESEARCH DEVELOPMENT CORPORATIONThe European Patent OfficeEP0138420Ceased
GG-GP39IMPROVEMENTS IN OR RELATING TO A STEROID COMPOUND AND PHARMACEUTICAL COMPOSITIONS CONTAINING ITGLAXO GROUP LIMITEDUnited KingdomGB2107715BExpired
GG-GP38INDIVIDUAL PARKING METERJON LIEUnknown JurisdictionGB2177836Ceased
GG-GP37OPTICAL FSK DEMODULATORTHE PLESSEY COMPANY PLCUnited KingdomGB2198904 BCeased
GG-GP35PLANE HOLLOW REINFORCED CONCRETE FLOOR WITH TWO-DIMENSIONAL STRUCTUREBREUNING, Jorgen IllnerThe European Patent OfficeEP 0 552 201 B1Expired
GG-GP34OPTICAL FIBRE STORAGE APPARATUSGEC PLESSEY TELECOMMUNICATIONS LTDUnknown JurisdictionGB2241221 BCeased
GG-GP33TDM DATA TRANSMISSION SYSTEMGEC PLESSEY TELECOMMUNICATIONS LTDUnited KingdomGB2218598 BCeased
GG-GP32IMPROVEMENTS IN OR RELATING TO ELECTRIC OSCILLATOR CIRCUIT ARRANGEMENTSGENERAL ELECTRIC COMPANY LIMITEDUnited KingdomGB1603616Expired
GG-GP31Digital Data Signalling Systems & ApparatusGENERAL ELECTRIC COMPANY LIMITEDUnited KingdomGB1489177Expired
GG-GP30HOUSING ARRANGEMENTS FOR ELECTRICAL/OR ELECTRONIC EQUIPMENTTHE GENERAL ELECTRIC COMPANY P L CUnited KingdomGB2196798 BExpired
GG-GP29POWER SYSTEM FOR TELEPHONY SYSTEMSGPT LIMITEDUnited KingdomGB2249239 BCeased
GG-GP27FIBRE OPTIC CONNECTORGEC PLESSEY TELECOMMUNICATIONS LIMITEDUnited KingdomGB2233787 BCeased
GG-GP25OXIMES DERIVED FROM ERYTHROMYCIN A, THEIR PREPARATION, THEIR APPLICATION IN PHARMACEUTICALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMROUSSEL-UCLAFThe European Patent OfficeEP 0 033 255 B1Expired
GG-GP24HERBICIDAL CYCLOHEXANE-1,3-DIONE DERIVATIVESICI AUSTRALIA LIMITEDThe European Patent OfficeEP 0 080 301 B1Expired
GG-GP22PIPERIDINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERSASTRAZENECA ABThe European Patent OfficeEP 1 499 590 B8Ceased
GG-GP21NEW 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVE (1)ASTRAZENECA ABThe European Patent OfficeEP 1 084 103 B1Ceased
GG-GP20METHOD FOR THE PREPARATION OF ARYL ETHERSPHARAMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 140 788 B1Ceased
GG-GP19(S, S)-REBOXETINE FOR TREATING MIGRAINE HEADACHESPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 459 751 B1Ceased
GG-GP18(S,S)-REBOXETINE FOR TREATING PERIPHERAL NEUROPATHYPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 459 748 B1Ceased
GG-GP17REBOXETINE FOR TREATING MIGRAINE HEADACHESPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 500 396 B1Ceased
GG-GP16(S, S)-REBOXETINE FOR TREATING INCONTINENCEPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 459 749 B1Ceased
GG-GP15REBOXETINE FOR TREATING PERIPHERAL NEUROPATHYPHARMACIA & UPJOHN COMPANY LLCThe European Patent OfficeEP 1 493 442 B1Ceased
GG-GP14PYRIDAZINO QUINOLINE COMPOUNDSASTRAZENECA ABThe European Patent OfficeEP 0 724 583 B1Ceased
GG-GP13PROCESS FOR PREPARING OXAZOLINES FROM TETRAHYDROFURANSAgouron Pharmaceuticals INCThe European Patent OfficeEP 1 224 177 B1Ceased
GG-GP12POLYMORPH OF 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINE-2, 4-DIONE MALEIC ACID SALTSMITHKLINE BEECHAM PLC AND SMITHKLINE BEECHAM (CORK) LIMITEDThe European Patent OfficeEP 1 173 435 B1Ceased
GG-GP11Triazine Compounds as AnxiolyticsTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 689 440 B1Ceased
GG-GP10USE OF 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1, 2, 4-TRIAZINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT CERTAIN TYPES OF PAIN AND OF OEDEMATHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 626 851 B1Ceased
GG-GP9HYPOLIPIDAEMIC BENZOTHIAZEPINE COMPOUNDSTHE WELLCOME FOUNDATION LIMITEDThe European Patent OfficeEP 0 626 952 B1Ceased
GG-GP81, 5-Benzodiazepine Derivatives and their use in medicineGLAXO WELLCOME SpAThe European Patent OfficeEP 0 558 104 B1Ceased
GG-GP7NEW FORMULATION FOR INHILATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, COMPRISING TERBUTALINE SULPHATE, A PROCESS FOR PREPARING THE FORMULATION AND THE USE THEREOFASTRAZENECA ABThe European Patent OfficeEP 1 014 955 B1Ceased
GG-GP6BENZOTHIAZOLONE DERIVATIVESASTRAZENECA ABThe European Patent OfficeEP 0850232 B1Ceased
GG-GP5MULTILAYER TABLET COMPRISING ROSIGLITAZONESMITHKLINE BEECHAM PLCThe European Patent OfficeEP 1 128 827 B1Ceased
GG-GP3MULTILAYER TABLET COMPRISING ROSIGLITAZONESMITHKLINE BEECHAM PLCThe European Patent OfficeEP 1 128 827 B1Ceased
GG-GP2FORM III CRYSTALLINE [R-(R*,R*)] -2-(4-FLUOROPHENYL)-BETA-DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[PHENYLAMINO) CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN)WARNER-LAMBERT COMPANYThe European Patent OfficeEP 0 848 704 B1Ceased
GG-GP1STABILISATION OF PHOSPHORIC ACID ESTERSHOECHST AKTIENGESELLSCHAFTUnited KingdomGB2000975Ceased